TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 3 | 1 | 3 | 1 | 2 | 12 | 12 | 2 | 20 | 8 |
| P | %wins | 33 | 67 | 67 | 67 | 33 | 100 | 61 | |||
| S | %ret | 1 | 1 | 1 | 0 | 0 | 4 | -23 | -74 | -78 | -43 |
| S | %wins | 100 | 100 | 0 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/27/15 18:33 | 4/23/15 | ESPR | Esperion Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aisling Capital II LP | NY | T | S.m | -23,534 | 108.22 | 33 | -217 | -5 | 3,742 | I | 616 | 351 | 126 | 41 | 4 | 3 | 1 | 0 | 0 | 4 | -23 | -74 | -78 | ||
10/23/13 16:25 | 10/22/13 | ADMA | Adma Biologics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Aisling Capital II LP | NY | T | P | 3,500 | 8.50 | 0 | 412 | 13 | 3,620 | I | -1 | -1 | -1 | -6 | -2 | -9 | 42 | ||||||||
7/1/13 16:33 | 7/1/13 | ESPR | Esperion Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aisling Capital II LP | NY | T | P.d | 3,334 | 14.00 | 18 | 238 | 13 | 2,055 | I | 4 | 7 | 26 | 33 | -7 | 13 | |||||||||
2/9/12 12:33 | 2/7/12 | CEMP | Cempra, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aisling Capital II LP | NY | T | P | 7,282 | 6.00 | 0 | 1,214 | 58 | 3,293 | I | -1 | 1 | 16 | 5 | 21 | 6 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |